Xcout Intel
Automera competitors & alternatives
The 12 closest competitors and alternatives to Automera among drug discovery companies — ranked by similarity to what Automera actually does, not by market-cap band.
Subscribe to see Automera’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Automera
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Automera at a glance
Automera is a drug discovery company headquartered in Singapore. Its most recent funding round, Series A, raised $16M in September 2023. Xcout tracks 7 named people at Automera, including Thong Q. Le (Chief Executive Officer).
Automera leadership
- Thong Q. LeChief Executive Officer
- Shawn HoonChief Scientific Officer
- Loong WangChief Technology Officer & Co-Founder
- Michael LazarouCo-Founder
- Pearly NgHead of Chemistry
- Alice ChenExecutive Vice President
1 more named person on record for Automera, with roles, board committees and tenure — see the full roster →
Automera funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $16M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Automera competitors
Ranked by semantic similarity — how close each company is to Automera by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
Similar drug discovery company
Promise Bio is a biotechnology research startup transforming immune-mediated disease treatment with advanced precision therapies. Headquartered in Tel Aviv, Israel, the company emerged from stealth following a seed investment.
Similar drug discovery company
PAQ Therapeutics is a clinical-stage biotechnology company that utilizes autophagy to develop small-molecule KRAS degraders for the treatment of lethal cancers. The company's research focuses on restoring health and curing diseases that currently lack effective treatment options.
Similar drug discovery company
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Similar drug discovery company
Albatroz Therapeutics is a pre-clinical stage biotechnology company based in Singapore that is developing first-in-class antibody therapeutics to protect the extracellular matrix and treat solid tumors.
Similar drug discovery company
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Similar drug discovery company
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Similar drug discovery company
Lighthouse Pharma is a clinical-stage private biopharmaceutical company that specializes in precision medicine approaches targeting major unmet medical needs. The company is headquartered at the Buck Institute for Research on Aging in California.
Similar drug discovery company
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Similar drug discovery company
Syntax Bio is a biotechnology research company headquartered in Chicago, Illinois, focused on synthetic biology. The company utilizes its proprietary Cellgorithm CRISPR-based platform to program stem cells and accelerate the development of next-generation organoids and cell-derived therapies.
Similar drug discovery company
META Pharmaceuticals Inc. is a pioneering biotechnology company focusing on immuno-metabolism and gastrointestinal therapeutics within immunology, operating research efforts connected to JLABS in Shanghai.
Similar drug discovery company
LyncBio Therapeutics is an innovative drug discovery and development company headquartered in Shanghai, China, with research facilities in Suzhou. The firm specializes in the advancement of antibody-drug conjugate (ADC) therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Automera and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Automeraand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →